SEC Form 4 · accession 0001209191-18-007236
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
P. Martin Paslick
Officer — SVP and CIO
Period of report
Jan 31, 2018
Accepted (ET)
Feb 2, 2018 · 7:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 1, 2018 | M | 75,000 | $22.87 | A | 75,895 | D | |
| Common Stock | Feb 1, 2018 | M | 35,000 | $22.95 | A | 110,895 | D | |
| Common Stock | Feb 1, 2018 | M | 56,813 | $102.24 | D | 54,082 | D | |
| Common Stock | holding | — | — | — | 26,248 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF1 | $101.16 | Jan 31, 2018 | A | 27,450 | A | Jan 31, 2019 | Jan 31, 2028 | Common Stock | 27,450 | 27,450 | D |
| Stock Appreciation RightF2 | $22.87 | Feb 1, 2018 | M | 37,500 | D | — | Aug 7, 2022 | Common Stock | 37,500 | 0 | D |
| Stock Appreciation RightF3 | $22.87 | Feb 1, 2018 | M | 37,500 | D | — | Aug 7, 2022 | Common Stock | 37,500 | 0 | D |
| Stock Appreciation RightF4 | $22.95 | Feb 1, 2018 | M | 17,500 | D | — | Feb 8, 2022 | Common Stock | 17,500 | 0 | D |
| Stock Appreciation RightF5 | $22.95 | Feb 1, 2018 | M | 17,500 | D | — | Feb 8, 2022 | Common Stock | 17,500 | 0 | D |
Explanation of responses
- F1The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019.
- F2The stock appreciation rights vested in four equal annual installments beginning on August 7, 2013.
- F3The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets.
- F4The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets.
- F5The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013.